PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Cell and Gene Therapy

Upcoming Events

SLAS Europe – 7th April 2025
PEGS Boston – 17/02/2025
Biotechnology Show 2025: 20th January 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025

Betting on the Bug: How the Microbiome Can Improve Reproducibility and Translatability

Investigators continually seek to improve the reproducibility of their results and the translatability of their preclinical work, while recognising that both goals pose challenges. In a 2016 Nature survey, over 70% of researchers said they were unable to reproduce another scientist’s study and over 50% had failed to reproduce their own studies. For evidence that translatability from the lab to the clinic remains problematic, one needs to look no further than the fact that nine out of 10 drug candidates fail at the clinical trial stage. Dr Alexander Maue at Taconic reveals how investigators can move beyond these obstacles and improve research outcomes.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/07/Betting-on-the-bug_how-the-microbiome-can.pdf” width=”100%” height=”900px” style=”border:0;”]

Newcells 3 June 2024, 15:12
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
Tosoh – 29.04.25
Eppendorf – 18.03.2025
Asychem – 10.04.2025
Taconic Biosciences – 29.04.25
Steribar – 12.05.2025